Funding for this research was provided by:
European Foundation for the Study of Diabetes
Danish Diabetes Academy
The Danish Medical Research Counsil
the Novo Nordisk Foundation (NNF10CC1016515)
European Union's Horizon 2020 research and innovation programme (667191)
Text and Data Mining valid from 2018-12-01
Received: 26 October 2017
Accepted: 14 November 2018
First Online: 4 December 2018
Ethics approval and consent to participate
: Prior to participation, participants signed an informed consent form. For minor participants (below the age of 18 years), the informed consent form was signed by a parent. The study was conducted in accordance with the Declaration of Helsinki II and was approved by the Ethical Committee of Copenhagen (KA 93033 and KA 93033gm).
: Not applicable.
: OP and TH hold personal shares in Novo Nordisk. All other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.